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Background: Ten years on from the National Institute of Health and Clinical Excellence’ technology appraisal guideline
on haemodialysis in 2002; the clinical community is yet to rise to the challenge of providing home haemodialysis
(HHD) to 10-15% of the dialysis cohort. The renal registry report, suggests underutilization of a treatment type that has
had a lot of research interest and several publications worldwide on its apparent benefit for both physical and mental
health of patients. An understanding of the drivers to introducing and sustaining the modality, from organizational,
economic, clinical and patient perspectives is fundamental to realizing the full benefits of the therapy with the
potential to provide evidence base for effective care models. Through the BASIC-HHD study, we seek to understand
the clinical, patient and carer related psychosocial, economic and organisational determinants of successful uptake and
maintenance of home haemodialysis and thereby, engage all major stakeholders in the process.
Design and methods: We have adopted an integrated mixed methodology (convergent, parallel design) for this study.
The study arms include a. patient; b. organization; c. carer and d. economic evaluation. The three patient study cohorts
(n = 500) include pre-dialysis patients (200), hospital haemodialysis (200) and home haemodialysis patients (100) from
geographically distinct NHS sites, across the country and with variable prevalence of home haemodialysis. The pre-dialysis
patients will also be prospectively followed up for a period of 12 months from study entry to understand their journey to
renal replacement therapy and subsequently, before and after studies will be carried out for a select few who do
commence dialysis in the study period. The process will entail quantitative methods and ethnographic interviews of all
groups in the study. Data collection will involve clinical and biomarkers, psychosocial quantitative assessments and
neuropsychometric tests in patients. Organizational attitudes and dialysis unit practices will be studied together with
perceptions of healthcare providers on provision of home HD. Economic evaluation of home and hospital haemodialysis
practices will also be undertaken and we will apply scenario ("what… if") analysis using system dynamics modeling to
investigate the impact of different policy choices and financial models on dialysis technology adoption, care pathways
and costs. Less attention is often given to the patient’s carers who provide informal support, often of a complex nature to
patients afflicted by chronic ailments such as end stage kidney disease. Engaging the carers is fundamental to realizing
the full benefits of a complex, home-based intervention and a qualitative study of the carers will be undertaken to elicit
their fears, concerns and perception of home HD before and after patient’s commencement of the treatment. The data
sets will be analysed independently and the findings will be mixed at the stage of interpretation to form a coherent
message that will be informing practice in the future.
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Discussion: The BASIC-HHD study is designed to assemble pivotal information on dialysis modality choice and uptake,
investigating users, care-givers and care delivery processes and study their variation in a multi-layered analytical approach
within a single health care system. The study results would define modality specific service and patient pathway redesign.
Study Registration: This study has been reviewed and approved by the Greater Manchester West Health Research
Authority National Research Ethics Service (NRES) The study is on the NIHR (CLRN) portfolio.
Keywords: Barriers, Home haemodialysis, Mixed methods, Qualitative, Organisation, Adoption, Quality of lifeBackground
Burden of ESRD
Chronic kidney disease (CKD) is a global public health
concern ([1,2]). The tip of the CKD ‘iceberg’ is manifest
in end stage renal disease (ESRD), when, to sustain
life, some mode of renal replacement therapy (RRT)
becomes necessary. Typically, there are three options
available to patients who would like to consider treat-
ment. These are transplantation (TX), home-based
dialysis (home haemodialysis-HHD and peritoneal
dialysis-PD) or hospital-based/In-Centre haemodialysis
(ICHD). The global explosion in uptake of dialysis in
the 80s and 90s, due to lack of availability of donor or-
gans to meet demands for transplantation, is a testi-
mony to the success of dialysis technology. However,
patient outcomes on dialysis have been poor, and in this
context, extended haemodialysis at home has delivered
the best results.
Management of ESRD with haemodialysis began in the
1960s. The use of HHD modality was at its peak in the
early 1980s (up to 2,200 patients), representing 61% of
haemodialysis patients. Hospital dialysis units expanded
across the UK in the 80s and 90s and ‘satellite’ hospital
units emerged trying to meet the demand - as they were
able to accommodate the ever increasing numbers of pa-
tients needing long term dialysis therapy. High rates of
attrition from home HD were noted in the 90s. The
prevalence of HHD modality dropped, to its usage in
just 445 HD patients (2.4%) in 2006 [3]. The evolution
of dialysis therapies has resulted in a gradual diminution
of home based therapies to be largely replaced by ICHD.
This phenomenon has posed a challenge to clinicians,
service providers and policymakers as scientific evidence in
recent times has proposed a strong argument for greater
adoption of this modality to improve patient outcomes on
dialysis. The optimal uptake of HHD modality with current
technology remains unknown. The case for HHD is made
from the evidence of its benefits on clinical outcomes (bet-
ter cardiovascular health, haemoglobin, blood pressure
control, medication burden, sleep, nutritional status, fewer
hospitalisations and better quality of life) compared to
facility-based haemodialysis. Furthermore, published data
have demonstrated extremely high technique survival rates
(hence sustainability) in HHD [4].Implementing home based therapies aligns closely with
the government initiative of providing care ‘closer to
home’. The Department of Health in the UK carried out an
extensive review of self-care support, encompassing large
numbers of systematic reviews, observations and surveys
in a wide variety of clinical conditions and found clear evi-
dence of beneficial health outcomes for patients and better
use of health and social care resources [5]. Studies support
cost-effectiveness of HHD when compared to ICHD. In
one systematic review of 27 studies undertaken between
1978 and 2001, eighteen of these considered cost effective-
ness and showed lower costs associated with HHD [6].
Even switching from hospital-based to home-based haemo-
dialysis would optimise cost effectiveness [7]. More appro-
priate economic analysis will require other considerations,
such as costs associated with home conversions, travel re-
duction, return to work and contribution thereby to the
economy. The broader societal economic benefits of home
haemodialysis include better full time employment of
home and nocturnal dialysis patients [8]. Many dialysis
units operate contracts with different funding sources and
there are several cost variables which need to be
considered.
Adoption barriers to home haemodialysis
Variation in the uptake and prevalence of HHD is a world-
wide phenomenon. Different health care systems, variable
practice and reimbursement models have been implicated.
Demographics, service provision landscape and social atti-
tudes have evolved over time. Comorbidities, such as dia-
betes, have been on the rise (32.7% diabetics starting RRT
in 2010). Within the last decade, there has been a resur-
gence of interest in HHD. This may account for the small
increase in the proportion of patients receiving haemodi-
alysis in their own homes since 2006 (up to 3.4% in 2010)
[3]. This however, falls far short of the NICE guidance.
Interestingly, despite national policy, NICE guidance, sev-
eral initiatives and interventions within a single health care
system (NHS), UK registry data suggest an atlas of vari-
ation in the proportion of dialysis patients receiving home
HD (0% in 13 centres, to >5% in 8 centres) [3].
In the last decade, very few studies have been done to
understand this phenomenon nationally and internation-
ally. Studies from several countries have contributed to
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adoption of home therapies in general (PD & HHD), may
be slow. Earlier studies [9] failed to show any association
between centre and patient demographics to modality
prevalence. An association study between social dep-
rivation and survival on RRT in England and Wales be-
tween 1997 and 2004, found inequitable access to RRT of
individuals from deprived areas, using the Townsend
index [10]. Patients who presented within 3 months of re-
quiring dialysis were less likely to receive a home dialysis
treatment in a survey by Lamiere et al. [11]. The impact of
therapy specific patient education on choice is highlighted
in several studies and does impact on home-based dialysis
therapies– although these studies have mainly focused on
PD [12]. The quality and duration of pre-dialysis educa-
tion and the level of support, in the form of a team of spe-
cialist nurses, may have an influence on the number of
patients choosing a home modality [13,14]. A systematic
study of the barriers to uptake of home dialysis, in the
USA [15], highlighted ‘current under-usage of home dialy-
sis and identified problem areas including, limited and
unmandated home dialysis training of nephrology fellows,
lack of synchronised education of ESRD care providers,
Medicaid services’ poor reimbursement policies which
dis-incentivises home based therapy’. In an Australian sur-
vey [16], the most commonly reported impediments to
expanding home dialysis services were operational and in-
frastructural factors such financial disadvantage for home
HD patients, and lack of physical infrastructure for train-
ing, support and education. Areas of concern for ex-
panding home dialysis programmes included psychiatry
support, access to respite care and home visits, and lack of
support from medical administration and the government.
Clinician’s bias to one or the other modality and poor ex-
posure to PD during training or recent completion of
training were found be associated with bias against home
dialysis therapies in general [17-20]. A different survey in-
vestigated reasons behind prevalent in-centre haemodialy-
sis patients, choosing not to perform self-care dialysis.
The outcomes suggest that ‘human factors such as, fear
of change in general, fear of social isolation, not being
prepared to stay awake on dialysis, time constraints
preventing self-care, needle phobia and fear of reduced
interaction were associated with a negative attitude to-
wards self-care dialysis’ [21].
Many surveys generally indicate the widespread belief of
physicians and care providers of the benefit of HHD which
is in sharp contrast to the practice of this modality in their
units. A survey by the Renal Registry demonstrated a
broad range of opinions about dialysis modality related
survival and quality of life reasons held by UK nephrolo-
gists [3]. In a large opinion based survey over 7000 neph-
rology health-care professionals were given questionnaires
at five major international dialysis conferences in 2006[22]. This survey identified patient motivation as one of
the strongest drivers of self-care dialysis at home. The
need for dedicated resources for staff to devote time to de-
veloping such motivation is given as one of the major rea-
sons for the slow adoption. Under ideal conditions, it is
felt that one-third of all patients starting dialysis can be
trained to perform self-care dialysis.
Limitations of published work
Most published analyses on adoption barriers to home
haemodialysis from the UK, have been limited by exam-
ining factors in isolation, or from studies based on opin-
ions, questionnaires and surveys which lack consensus.
Many such surveys and studies are limited by gathering
views of home haemodialysis enthusiasts. Registry data
collection is limited to the clinical dataset and does not
incorporate delivery aspects, patient reported outcomes
and factors that define treatment preference and path-
ways of this modality. Investigating centres with variable
practice and uptake (high, low or absent) simultaneously
can potentially eliminate bias and provide more comple-
mentary and valid datasets for comprehensive analysis and
interpretation. There is published literature of interview-
based studies involving small numbers of home and
hospital based HD patients. Whilst they highlight the per-
ceived problems with home HD procedure, they have not
been solution seeking and the choice of patients for such
qualitative studies, has not been systematic. Besides, studies
have not captured the journey of the predialysis patient in
the months preceding the start of dialysis, when the crucial
decision making process is initiated. It is also apparent that
very few studies have a focus on the views of predialysis pa-
tients in preparation for commencement of renal replace-
ment therapy, and in those where they have been included,
HHD may not have been one of the modality choices
on offer. Given the complexity of the decision-making
process, further work with sufficient patient numbers is
needed, to fully understand the nuances specific to home
haemodialysis. In addition to patient clinical factors influen-
cing their psychosocial state and choice of modality, a
greater understanding of the complex interplay of patient
and organisational factors and their impact on the adoption
of home haemodialysis therapy is not available at the
present time.
Study objectives
The primary objective of the BASIC-HHD study is to
conduct a comprehensive and systematic study of the
barriers to and enablers of successful uptake and main-
tenance of HHD across multiple centres with low,
medium and high prevalence rates of home HD. Care
pathways of predialysis, incident and prevalent dialysis
patients will also be investigated under clinical, psycho-
social and organisational domains.
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a) Investigate biomarkers and their links
to cognitive attributes utilised in decision making
in ESRD.
b) Analyse scenarios of the uptake of different
dialysis modalities over time and assess the
impact on service design (based on system
dynamics modeling)
c) Assess impact of centre infrastructure,
policy and regulations on implementation
dynamics of HHD
d) Conduct an economic evaluation to examine
efficiency savings and value
e) Evaluate carer perspectives and burden in the
treatment journey of the patient
We believe that such study of HHD uptake, examining
barriers and drivers at various levels, using a multi-layered
approach that examines patient and organisational factors
in parallel using mixed methods (parallel and convergent
design) is an ideal methodology to address the research
question. A comprehensive study, would aid development
of a model of adoption of HHD, which would incorporate
variables from both qualitative and quantitative studies.




This is a multicentre, prospective, observational cohort
study using mixed research methods (combined qualita-
tive and quantitative). Predialysis (CKD-5), incident and
prevalent hospital and HHD patients will be studied.
The predialysis (CKD-5) cohort will be followed pro-
spectively. A convergent, parallel mixed methods design
will be employed to study the cohorts. This means that
quantitative and qualitative data will be collected, inde-
pendent of each other in a single phase, i.e., concur-
rently. Both quantitative and qualitative datasets will be
analysed separately and comparing or combining the re-
sults of the quantitative and qualitative analyses will
occur at the stage of interpretation.
Setting
The study is currently underway in the United Kingdom
across five centres, in different geographic regions. By de-
sign, the centres recruited into the study, have variable
prevalence of HHD and categorised to low (<3%), medium
(5-8%) and high (>8%) prevalence centres. This heterogen-
eity provides an important backdrop to the study setting
allowing the study of both centre and patient characteris-
tics which might influence the local adoption of this mo-
dality. The centres in the study have been chosen on thebasis of UKRR information on the HHD prevalence
as of June 2010. Several centres also approached the
host centre and the final centre participant list for
the study was drawn, primarily based on resource
availability at the local centres and the size of their
home HD/RRT programme.Ethical approval
This study has been reviewed and approved by the Greater
Manchester West Health Research Authority National Re-
search Ethics Service (NRES) Reference number: 12/NW/
0170. The study is on the NIHR (CLRN) portfolio, bearing
ID number 12346.Study organisation
The BASIC-HHD organisation structure operates from
the host centre (MRI). Host centre study team will han-
dle overall management of the study at all centres,
through recruitment of research nurses under the
supervision of a principal investigator at each one of the
participating centres.
The individual centres will manage participant recruit-
ment, data collection and data transfer. The host institu-
tion will address protocol education of nurses and
colleagues in the participating centres and also help obtain
site specific R&D approval prior to commencement of the
study (Figure 1).Quantitative study arm
Inclusion/exclusion criteria
Participant inclusion criteria Participants are eligible
for INCLUSION in the study if the following criteria
are met-
1. Pre-dialysis patients who are under
specialist renal team for management of
advanced CKD will be considered for inclusion
in the study, from either of these groups-
2. The CKD patient at recruitment, will have
eGFR < 10 mls/min (OR) if eGFR between 10-
20 mls/min; anticipated dialysis start within 12
months
3. Prevalent conventional HD (in-centre) patients of
variable dialysis vintage (minimum time on
modality-8 weeks)
4. Prevalent HHD patients of variable dialysis vintage
(minimum time on modality-8 weeks)Participant exclusion criteria Patients will be EX-
CLUDED from the study if, in the opinion or knowledge
of the responsible clinician, any one of the following cri-
teria is present:
Figure 1 Schematic representation of the scope of the BASIC-HHD study.
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renal team for at least 3 months
2. Life expectancy < 6 months
3. Plans for renal transplantation (Live Donor
Transplant) within 6 months of entry into study
4. Inability to complete questionnaires or face-to-face
interviews
5. Concomitant major illness limiting assessments and
follow-up
6. Factors limiting the offer of home haemodialysis
such as uncontrolled psychosis/anxiety, severe
learning disability, on-going drug/alcohol abuse,
uncontrolled seizure disorder, dementia/poor short
term memory.
Patient participants
Written consent will be obtained from all patients prior to
recruitment into the study. Prevalent and incident haemo-
dialysis patients and predialysis patients will be approached
for the study.
a. Patients in preparation for RRT, naive to dialysis
(COHORT A)
We aim to recruit about 50 pre-dialysis patients
from each centre. The anticipated total number of
predialysis patients in the study is about 200.
Patients will be identified from the prevalent pool
(those known to specialist renal team for at least
3 months) and others may need to be recruited
prospectively, as they are referred to the advanced
chronic kidney disease clinics. To generate a
comparator cohort with the reference group(HHD group), some patients recruited will be age
(within 5 yrs.) and gender matched with the HHD
group (same number as the number of home
patients recruited at each centre). The rest of the
patient recruitment into this cohort will take into
account the diversity in demographics of the
presenting ‘pre-dialysis’ population.
b. Patients established in centre HD (COHORT B)
We aim to recruit about 50 pre-dialysis patients
from each centre. The anticipated total number of
predialysis patients in the study is about 200.
Patients will be identified from the prevalent pool
(those known to specialist renal team for at least
3 months) and others may need to be recruited
prospectively, as they are referred to the advanced
chronic kidney disease clinics. To generate a
comparator cohort with the reference group
(HHD group), some patients recruited will be age
(within 5 yrs.) and gender matched with the HHD
group (same number as the number of home
patients recruited at each centre). The rest of the
patient recruitment into this cohort will take into
account the diversity in demographics of the
presenting ‘pre-dialysis’ population.
c. Patients established on HHD (COHORT C)
From the prevalent and incident HHD pool, variable
numbers of patients will be selected from each
centre. All HHD patients from the 5 centers will be
screened for eligibility. Based on the prevalence rates
across all centres, it is expected that about 100
home haemodialysis patients would be able to
participate in the study, subject to eligibility.
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dialysis modality COHORT D.
This group is derived from cohort A and will
comprise of patients who have started a modality of
renal replacement therapy during the 12 months
from recruitment. It is anticipated that a third of the
patients would have commenced dialysis.
Duration of subject participation
Individual participants will participate, up to a total of
12 months from recruitment into the study, unless
a. Patient chooses to withdraw from the study
b. Patient develops a major illness within 3 months of
study entry that will preclude any assessments or
follow-up, necessitating withdrawal from the study
c. Terminal Illness
d. Patient death
Some pre dialysis patients, who may have had to start
renal replacement therapy relatively early in the course
of the study, will be able to complete participation in the
study early.
Recruitment size and population (Figure 2)
Follow-up visit
All predialysis participants (A) who have given consent to
join the study; will be seen after consent, typically when
they attend pre-dialysis clinic as per their usual clinic
schedule or on a separate day if they so wish. Predialysis
patients will also be reviewed >4 months after start of dia-
lysis. During each one of these visits, patients will haveFigure 2 Schema of recruitment size and population.blood sampling and neuropsychometric tests. Question-
naires measuring potential psychological predictors of mo-
dality choice and adherence will be given on the day and
reminders to return the questionnaire will be sent on 2 oc-
casions, one month after handing them out.
All hospital HD (In-centre) patients (B) who have given
consent to join the study will have baseline information
and laboratory samples collected at the time of their regu-
lar dialysis schedules. To standardize the research activity
in this cohort, all patients will be seen just before com-
mencement of haemodialysis and all neuropsychometric
tests will be carried out mid-week (Wednesday for Mon/
Wed/Fri schedule and on a Thursday for a Tue/Thurs/Sat
schedule). Blood sampling will be obtained before com-
mencement of dialysis. To ensure a consistent return rate,
patients will be requested to complete the questionnaires
in hospital, whilst on dialysis and in the first hour of treat-
ment. No further visits will be required.
All home HD patients(C) who have consented to par-
ticipate in the study will have their baseline information
collected in a dedicated clinic for the study, which will be
mid-week (Wednesday for Mon/Wed/Fri schedule and on
a Thursday for a Tue/Thurs/Sat schedule) and preceding
their dialysis schedule by no more than 4 hours. At this
time, blood sampling and neuropsychometric tests will be
carried out and patients will be requested to complete the
questionnaires at home. Time from/to the dialysis session
will be documented by the patients. No further visits will
be required.
Patients from all cohorts will participate in answering
the questionnaires. Non English speaking patients will have
the opportunity to answer these queries with the help of an
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may not be available in all languages. These questionnaires
will be given in a booklet to patients. Dialysis patients will
be advised to answer these questions within the first hour
of dialysis, so as to avoid the effects of haemodynamic
changes on the output. Two attempts will be made to sur-
vey the patient cohorts in a 3 month period. These ques-
tionnaires will be repeated >3months after commencement
of dialysis in the prospectively observed pre-dialysis cohort.
All questionnaires will be reviewed for completeness and
be manually scored and crosschecked by a second member
of the team.
Collection of biological samples
Samples will be sent to the Renal Research Labs for pro-
cessing and storage. DNA, plasma, cells and a clinical/
demographic data set will be held in the laboratories for
research, with patient consent. The samples will be
obtained from patients at the host centre and frozen in
the biobank storage at −80°C, within two hours of collec-
tion. This is with a view to study uraemic ‘neuro’toxin as-
says in these patient cohorts. This remains the subject of a
further study relating neurochemistry and behavioural
biology. Many of the biochemical parameters being evalu-
ated would be obtained routinely during the course of
their medical management and would help in quantifying
treatment and disease burden and illness related complica-
tions. These samples will be analysed at the South
Manchester University Hospital laboratory (Figure 3).Figure 3 Synopsis of data to be obtained in the BASIC-HHD study.Instruments employed in the study and rationale
All participants from the three study cohorts will
complete questionnaires based on measures of psycho-
social factors which are thought to be predictive of up-
take and maintenance of HHD, providing us with a
quantitative measure of psychosocial state. The ques-
tionnaires have been chosen to obtain information on
predictors of outcomes rather than the outcomes only.
These combined with interviews will add robustness to
the data. The instruments which are being employed as-
sess various aspects of human behaviour, illness percep-
tion, state of mind and quality of life.
Healthcare necessarily involves interpersonal contact.
This is particularly relevant in end stage renal disease. Cli-
nicians wishing to observe their patients’ interpersonal
styles will find descriptive prototypes of adult attachment
quite useful. ‘An understanding of interpersonal styles may
allow clinicians to adapt medical care to the strengths and
vulnerabilities that follow from particular patterns of adult
attachment’ [23]. The outcome of this ‘attachment style’
questionnaire will be the first one of its kind in the context
of ESRD and the correlation of the questionnaire output
with the demands of interpersonal interaction across the
modes of dialytic therapies will be made amply clear. Au-
tonomy preference index scale of Ende et al. [24] has been
used in this study. It was designed to measure preferences
for autonomy in decision making in a general sense, as
well as the extent to which people prefer doctors or them-
selves to make specific management decisions in three
Jayanti et al. BMC Nephrology 2013, 14:197 Page 8 of 15
http://www.biomedcentral.com/1471-2369/14/197clearly defined clinical vignettes. These hypothetical situa-
tions have been used as in the original document, without
any modification, as it best represents the stable situation,
a moderately severe clinical state and a severe episode re-
quiring hospitalisation, which are not specific to ESRD pa-
tients, but are unlikely to be unknown to them. The desire
to be informed and participate in decision making, will be
a desirable attribute in the context of ESRD, and its meas-
urement reflects actual patient preferences. Whether deci-
sion making equates to autonomy is a different question
and could well be the limitation of this tool.
The SF-36 is a modified version of the Medical Out-
comes Study questionnaire. It is a generic instrument with
36 questions, without questions specific to ESRD. It is a
reliable and valid tool which has been used in various pa-
tient populations, including ESRD [25-27]. There are eight
scales describing domains of physical function, social,
physical and emotional role function, mental health, bodily
pain, vitality and general perception of the state of health.
Depression is particularly unlikely to be recognized in
patients with end-stage renal disease (ESRD) because
symptoms of depression may overlap with those of urae-
mia. Consequently, prevalence estimates of depression vary
widely from 6% to 34%, depending on the diagnostic in-
strument and cut off point used [28,29]. The Beck Depres-
sion Inventory (BDI), which has a sensitivity of 92% and a
specificity of 80% using a cut off of 15 [30] is being used to
screen patients for depression, whilst also assessing their
cognitive state. The BDI is a self-report inventory that has
been extensively validated and used for measuring depres-
sion in various population groups, particularly in dialysis
patients [31,32]. Although depression in haemodialysis
population is well studied, anxiety is also recognized to be
a very important problem in dialysis patients. Anxiety may
be present independent of other problems or somatised as
part of another mental ailment. In this study we have
employed a widely used tool for measuring anxiety-
Spielberger’s State-trait anxiety Inventory [33]. It clearly
differentiates between “state anxiety” and “trait anxiety”.
The inventory’s simplicity makes it ideal for evaluating in-
dividuals with lower educational backgrounds too.
The Illness Perception Questionnaire-revised (IPQ-R) as-
sesses the following illness perceptions- identity, chronic
timeline, cyclical timeline, treatment control, personal con-
trol, coherence, causes and emotion reaction. Across sev-
eral illnesses, the reliability and validity of the IPQ-R has
been demonstrated [34]. There is now evidence towards
the validity and reliability of the IPQ-R as suitable measure
of illness perceptions in the context of ESRD [35,36]. Ill-
ness perceptions drive coping and self-management behav-
iours and hence are an important measure in this study.
Home modalities of renal replacement therapy, are very
demanding of memory. Beliefs about one’s potential to use
memory efficiently will influence self-selection of suchtherapy [37,38]. Also, individual differences in self-rated
memory do not correlate well with objective memory
tests- this may imply that people’s beliefs about their mem-
ory are inaccurate [39]. This is at least true of the general
population. The metacognition questionnaire has two
components - the meta-memory and meta-concentration.
Additionally, this questionnaire has items worded that are
consistently ‘positive’ and avoid a deficit connotation [40].
This has been used in elderly patients, but the questions
have no specific age-focus and are applicable to the ESRD
population, for the purpose of this study.
To allow for a comprehensive understanding of cogni-
tive function, multiple measures must be included in the
neuropsychological test battery. The tests would consider
different domains of brain function- psychomotor effi-
ciency and processing speed, learning efficiency and at-
tention. Greater understanding of patient’s cognitive
state can be attained through combining subjective
cognitive function, for self-reported everyday func-
tioning, in addition to the cognitive psychometric
tests. The neuropsychometric tools to be employed
are: 3MS/Trail making tests and Digit span test. All
neuropsychometric tests and the meta-cognition question-
naire will be conducted in the mid-week, pre-dialysis
phase for dialysis patients. This helps standardise the
data collection across all centres. All sighted and lit-
erate patients will be invited to participate in these
tests.
In addition to the outcomes of questionnaire based
psychosocial outcomes, any potential association with
readily measurable biomarkers could inform day to day
clinical management of patients presenting in advanced
CKD clinics.Patient study arm- qualitative
For an in-depth exploration of individual perceptions of
problems and solutions, semi-structured interviews will
be carried out and this process will help define the be-
liefs, behaviours, attitudes and sensitivities of patients in
the different study cohorts. For the qualitative strand, a
purposive sampling technique will be employed. The
strategy best used in our study is one of maximal vari-
ation sampling, such that diverse individuals are chosen
who are expected to hold diverse perspectives on the
central theme, and their views will reflect a rich and
complex picture of the reality. The qualitative idea is not
to generalize from the sample but to obtain an in depth
understanding of the issues in a few people who have
been sampled, unlike the quantitative study arm.
The study sample will comprise pre-dialysis patients
(Cohorts A + D), home haemodialysis patients (Cohort
C) and hospital haemodialysis patients (cohort B). All
adult patients aged 18 and over, with end stage renal
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sion criteria, will be considered eligible for the study.
The aim is to conduct about 20 interviews in each co-
hort or until thematic saturation is attained.
A recruitment grid is designed taking into consideration
three factors- age, gender and ethnicity. Although it is not
a requirement for recruitment, every effort will be taken
to include patients with varying comorbidity profile.
English, Hindi and Urdu speaking patients would be con-
sidered, representing the local population demographics.
Participants will be approached at their regular clinic
consults by researchers with the study information leaflet
and consent form. Where the patient expresses a willing-
ness to consider participation, telephone contact will be
made after a minimum of 24 hours of providing informa-
tion. At this time, any questions will be answered and if
the participant remained willing, an appointment for the
interview will be scheduled. In a majority of instances this
would be in the patient’s own home or at the patient’s re-
quest, the venue would include the hospital. Suitably
qualified individuals will carry out the interviews. All in-
terviews will be one-to-one. They will be audio-taped and
then transcribed verbatim.
For purposes of the study, an interview schedule or
topic guide has been developed with a view to cover the
following areas-
a. Barriers and enablers of home haemodialysis as
patients perceive them
b. The potential solutions as seen by patients
c. Impact of self-cannulation on decision-making
d. Views on assisted home haemodialysisCarer study – qualitative
Participant eligibility (carers)
All adult carers (aged 18 and over) of patients undertaking
home haemodialysis or carers of patients who are in the
decision-making process, who meet the inclusion criteria
and none of the exclusion criteria will be considered
eligible for this study.Carer Inclusion criteria
Participants are eligible for INCLUSION in the study if
the following criteria are met-
– The patient needs to consider the individual to be
their carer.
– The individual self-defines themselves as the
patient’s carer.
For the purposes of this research, a broad definition of
the carer’s role is employed. A carer in the context of home
haemodialysis is understood to range from providingemotional support to the patient, to taking a degree of
responsibility for the patient’s dialysis procedure (Blogg
and Hyde, [1]).
Carer exclusion criteria
Participants will be EXCLUDED from the study if, in the
opinion or knowledge of the interviewer, either of these
criteria is present:
– An established primary care diagnosis of psychiatric
illness
– A life-threatening physical illness
The participant information sheet will be provided
to the participant, to make an informed decision
concerning in the study. A copy of the signed informed
consent and information sheet will be given to the
carer. Carers will undertake semi-structured interviews,
at a place of their choosing- their homes or at the hos-
pital. About 20 carers will be interviewed or until the-
matic saturation is attained. All interviews will be
audio-taped and transcribed verbatim. Adequate steps
will be undertaken to ensure that distress, if any,
caused to them when they verbalize their fears will be
dealt with appropriately and professionally.
Provider study arm – qualitative
Alongside patient assessments, investigators will obtain
information pertaining to the centres offering home
haemodialysis. More specifically, this study seeks to
help policymakers and renal care providers to under-
stand and overcome barriers to delivering complex,
patient-led medical procedures in the home by address-
ing the organizational, financial and policy influences
on the uptake of HHD. This research project investi-
gates how regulation, reimbursement rules and health
policy impacts the provision of care for patients with
chronic kidney disease.
Specific questions which will be posed include-
1. What factors impact on the adoption of
technological innovations in renal care, especially
home haemodialysis?
2. How do factors such as cost and financial
arrangements (e.g. payment, incentives or penalties),
implementation (e.g. training), intra-organisational
issues (e.g. clinical leadership, resistance of
incumbents to innovation), or environmental context
(e.g. space at home, distance between home and
clinic) limit the use of home haemodialysis to a level
far below of what is generally considered desirable?
3. What impact do financial regulatory changes
(e.g. PbR and the ‘best tariff practice’ in the UK,
bundling of services and changes to reimbursement
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behaviour of healthcare professionals and on
care provision?
4. What impact will different policy choices and
payment regulations likely have on the use of
different dialysis modalities in the future?Research approach
This study will combine qualitative research through inter-
views with modeling. The interviews will address research
questions 1, 2 and 3 and modeling will address question 4.Design
This is a comparative multi-centre study. It will employ
qualitative methodology in the form of 45 to 60 minutes
in-depth semi-structured interviews. Data from the
qualitative case studies and background interviews will
be used to inform simulation modeling exercises to in-
vestigate the implications of implementing HHD under
differing policy and financing options, and with differing
care provision models.Respondents
The background interviews will involve selected partici-
pants from leading (i) dialysis service organizations, (ii)
dialysis machine design and manufacturing firms, (iii)
national renal policy-making bodies.
The case studies interviews will involve (i) healthcare
professionals, (ii) managers of selected renal care cen-
ters. The aim is to interview all personnel involved in
the modality decision making process as well as the care





Although the study is not powered to evaluate a definitive
economic benefit of HHD, we will estimate costs related
to hospitalizations, medications and cost-utility from the
provider’s perspective based on data from at least 2 case-
study sites. The study will analyse the incremental costs of
providing HHD, including direct costs (disposables, equip-
ment, personnel, training, monitoring and technical ser-
vices) and in-centre costs (HD unit overhead). We will
also explore the potential impact of policy choices and fi-
nancial conditions on HHD implementation under a var-
iety of scenarios. We will use simulation modeling to
analyse such impacts on patient flows through the system,
the choice of dialysis modality and costs.Provider study arm-quantitative
From the different centres participating in the study,
centre specific information will be obtained. The broad
areas where detailed information will be sought include-
a. Infrastructure
b. Predialysis education and preparation
c. Training for HHD
d. Post-Discharge support structure
Dialysis unit staff-attitudes and practices (Organizational
Culture Inventory®)
Understanding the collective thought processes informing
a certain type of practice or behaviour is fundamental to
effecting the desired change. The use of a quantitative in-
strument together with ethnographic approach followed
by triangulation of results is likely to give a more complete
picture of the practice in a unit. Such an approach in an
area like dialysis methods has not been undertaken before
and would add value to the information available. ‘The
main appeal of such a method, lies in seeking to engage
organizations and their problems on the level of meaning’
[41]. One may not assume that everyone has a similar un-
derstanding of the issues and may have opinions and judg-
ments that vary from the perceived norm.
This Inventory by Cooke and Lafferty, is a quantitative
measure of the culture in the unit/organization [42]. It
evaluates the shared norms and expectations that guide
thinking and behaviour of group members. It has previ-
ously been employed in the healthcare sector. It has 120
pre-defined questions and will have 20 additional ques-
tions introduced specific to the study context. The re-
sponses are made in a 5 point Likert scale. It is likely to
take up to 20–25 minutes for completion. The tool has
good face validity, and strong psychometric underpinning.
Results can be graphically illustrated. The problems may
be encountered with the length of the tool, but sufficient
time will be given to staff to engage with this tool, as we
investigate its application in a novel context.
Data protection
Each patient enrolled into the study, is assigned a unique
identification number. All personal identification data are
stored in hospital computers only and separated from
medical and research data. Biological samples are iden-
tifiable only with their unique sample identifier and no pa-
tient identifiers are available within the Biobank. All
information pertaining to OCI® from specific centres are
only known to the lead researcher and not available to the
organisation that holds the license to conduct the survey.
Quality assurance
In order to ensure consistent performance across all
centres, single researcher (AJ) has conducted induction
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cleaned and examined to ensure data entry is accurate
and missing data is minimised. The database is backed
up regularly to ensure no loss of data. Biological samples
obtained are collected, processed and stored in appropri-
ate conditions and by certified personnel. All qualitative
aspects of the study will be reviewed by at least two
qualified researchers. All costs related information will
be procured after checking relevant documents from ap-
propriate authorities.Enrolment to-date
Enrolment as of the end of April 2013 comprises a total
number of 350 patients across five centres. It is antici-
pated that the recruitment period will end in late 2013.
Recruitment for the qualitative aspects of the study is
about 75% complete.Data analyses and statistical considerations
Quantitative data analysis
The sample size of the BASIC-HHD study of 500 pa-
tients was chosen as a realistically attainable cohort size
based on feasibility considerations. This sample size en-
sures adequate statistical power to differentiate cohorts
showing different behaviours with respect to the primary
and secondary objectives. The power analysis is also
based on the effects expected in the clinical measures.
Demographic data will be reported using means and
standard deviations (for normally distributed data) or
median and interquartile/full ranges (for skewed data)
where appropriate. Simple comparisons between base-
line data from the three study cohorts will be made
using two-sided tests; analyses of variance for normally
distributed data, Kruskal-Wallis for non-normal con-
tinuous data and ordinal data, and chi-square tests for
categorical data, with the conventional 5% significance
level. Individual cognitive test scores will be reported as
mean and standard deviations. Scores will be reported
both as normalized scores. In normalized scores, data
are fit to a normalized scale allowing direct comparisons
across scores. Factors which influence uptake and main-
tenance will be identified using multiple logistic regres-
sion analysis of the pre-dialysis cohort. Comparisons
between the HHD (C) and Hospital HD (B) cohorts will
use t-tests, Mann–Whitney U-tests and chi-square tests
as appropriate, followed by multiple logistic regression
analysis to identify significant independent discrimin-
atory factors. The study will have 80% power to detect
differences in the percentage of patients having particu-
lar factor attributes of 19% or more between the age-sex
matched cohorts of 100 patients (i.e. 20% vs. 39%,
equivalent to an odds ratio of approximately 2.5). For
the pre-dialysis patients, of whom 10% are estimated totake up home haemodialysis, the study will have 80%
power to detect prognostic factors with an odds ratio of
4 or more for the whole cohort of 200 patients.
Qualitative data analysis
The interviews will be analyzed using thematic analysis, a
methodologically and epistemologically flexible approach; it
is partly guided by the aims and the research questions
stated at the beginning of the project and partly guided by
the researcher’s active identification of themes based on the
accounts of participants’ own views and experience. At least
two researchers will analyze the interviews independently
ensuring the reliability of the analyses. The initial coding of
each interview will be compiled by both researchers inde-
pendently, and the coding frames and themes will be re-
fined and elaborated collectively in a dynamic way as more
data gets collected. As sequential analysis progresses, sig-
nificant data will be compressed so as to adhere around
several analytic schema. In order to ensure the reliability of
the qualitative analysis, the application of the coding frame
by independent researchers will be periodically cross
checked to establish a degree of uniformity.
Several techniques will be used to ensure the validity
of the qualitative analysis including:
 Respondent validation
 Triangulation: (by looking for commonalities and
anomalies at a sample level)
 Fair Dealing: our theoretical sampling approach
explicitly aims to incorporate a wide range of
different perspectives
Simulation modeling analysis
Using national and international renal patient registry data
in addition to our findings from interviews and our ana-
lysis of the literature, we will also apply scenario ("what …
if") analysis using system dynamics modeling to investi-
gate the impact of different policy choices and financial
models on dialysis technology adoption, care pathways
and costs. This will allow us to explore the factors influen-
cing the choice of dialysis modalities and develop a num-
ber of scenarios of the likely development under a range
of policy options (including changes in reimbursement/
funding rules). The modeling explore the role of the fac-
tors identified as barrier and drivers in the case studies
and also draw on the literature review, the data collected
in the background interviews with industrialists, policy
makers and healthcare professionals, historical registry
data and policy documents.
Integration of qualitative and quantitative data and
study outcomes
Combined qualitative and quantitative research methods
are finding increased acceptance in clinical and biomedical
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informed by a research strategy. The study of adoption
barriers to uptake of home haemodialysis would ideally in-
volve research in clinical and biological factors interacting
with psychosocial influences on health of the individuals
concerned and health services delivery research simultan-
eously. It is also important to understand these together as
there is little point in developing services or measuring pa-
tients’ outcome of health care, without an understanding
of how people’s beliefs and expectations about health, ill-
ness and treatment regimens on offer may interact with
those of health professionals, and thereby influence uptake
of services and adherence to therapy.
The choice of methodology to evaluate our research
question is one of mixed methods. This choice evolves
from a ‘pragmatist’ world-view which embraces para-
digms that influence and underlie the conduct of quali-
tative and quantitative research methods, through a
social science theoretical lens. The BASIC-HHD study
will adopt a dynamic, synergistic approach [43] to the
design process. This implies that, the sum of quantitative
and qualitative research is greater than either approach
alone.
Rationale for mixing methods
Bryman, in his work, offered 16 different reasons for
why one may choose to mix methods in research [44].
In our study, multiple reasons may be cited and new
reasons may emerge as the study is underway. The fol-
lowing tabulation of typology of reasons (adapted from
Bryman) helps understand the purpose of the method-
ology (Table 1).
The four key decisions in the choice of design
These decisions address the different ways in which the
quantitative and qualitative strands relate to each other.
The strand refers to the component of the study thatTable 1 Typology of reasons for mixing methods
Terminology Explanation
Triangulation Qualitative and Quantitative methods might
be combined so as to mutually corroborate
the findings
Offset The methods have their own strengths and
weaknesses, so combining the two would allow
to offset the weaknesses and draw on strengths
of both




The two methods can answer different research
questions
Explanation The findings of one method may be used to
explain the findings of the other
Credibility Employing both approaches enhances the
integrity of the findingsencompasses the basic process of conducting qualitative
or quantitative research: the question, data collection,
data analysis and interpretation of results [45].
a. The level of interaction between the qualitative and
quantitative strands: In our study, the
implementation of the two strands will be
independent of each other, i.e., the data collection
and analysis will be separate, and the two will be
mixed when drawing overall conclusions at the end
of the study.
b. The priority of the quantitative and qualitative
strands: The two strands will have equal emphasis
i.e., both will have an equally important role in
addressing the research question.
c. The timing of the quantitative and qualitative
strands: The timing of the two strands will be
concurrent, i.e., both methods will be employed in a
single phase.
d. Mixing the strands: Mixing also referred to as,
combining and integrating, is the explicit
interrelating of the two strands, and this point of
interface during our study, will be at the stage of
interpretation of the results of data analysis. Primary
mixing strategy is- merger after separate data analysis.
Crystallisation of findings from both components will be
reported when discussing the results of the study. There is
scope for comparison of raw datasets of one individual
from both methods, as an example, the interview tran-
script and questionnaire reports can be compared and pat-
terns looked for across cases. The notation system for this
mixed methods design is QUAN + QUAL, i.e., both
methods occur concurrently [46].
Study outcomes
The quantitative and qualitative studies which are being
undertaken to understand patient clinical and psycho-
social parameters, in the context of healthcare infrastruc-
ture and provider views from geographically distinct sites,
will give the breadth and depth of problem perception and
solutions. We seek to identify systemic issues that may
deter the uptake of HHD and understand factors which
may define the atlas of variation, to develop a tool to im-
plement a practice changing model of care. Additionally,
the study will highlight the beliefs and concerns of the
major stakeholders- patients, care givers and healthcare
providers on HHD. We will be able to ascertain the range
of interventions and assistance that may be necessary for
successful adoption. The association (if any) between
patient-psychosocial factors and biochemical parameters,
including specific toxin assays in the context of ESRD will
also be analysed. The study findings will be disseminated
to clinicians, organisations and health care strategists as
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mentation of the study design would also pave way for
more holistic research of chronic diseases in health care
systems using this methodology.
Discussion
Over the last five decades, the growth in demand for dialy-
sis has increased exponentially. There is a growing need to
develop methods for improving treatment outcomes whilst
paying attention to costs. It is in this context, that there is
renewed interest in home haemodialysis. The proposed
benefits in HHD offering extended dialysis schedules are
supported by randomised controlled trials and several ob-
servational studies. Despite the rhetorical remarks on the
benefits of HHD, its practical uptake has been somewhat
slow over the last decade and steps are being taken to in-
crease its adoption, in the UK and globally. In the study of
adoption of a well understood, complex intervention, such
as home haemodialysis, a robust study methodology is
important to delineate the issues facing the patients, care-
givers and healthcare providers. Partnerships will be
required between all stakeholders to adopt changes in atti-
tudes, with the necessary regulatory alterations to imple-
ment clinically superior, patient-focused dialysis treatment
programs, where informed patient choice is paramount.
Methodology is the rationale and philosophical assump-
tion underlying a particular study and not merely, a collec-
tion of methods, although, methodology leads to and
informs methods. Mixed methods papers in the field of
nephrology are very few [47]. Historically, studies have
been done to understand some aspects of this rather large
question on ‘barriers and enablers of home haemodialysis’.
Reports on different aspects of this issue, come from study
designs which do not automatically lend themselves to ac-
curacy or detail. These include close-ended questionnaire
based surveys, completed probably, by individuals who
are driven enthusiasts propagating home haemodialysis,
thereby introducing bias. In some instances, home dialysis
incorporating peritoneal dialysis and home haemodialysis,
have been studied and although, this would capture the no-
tion of ‘self-care’, nuances, specific to home haemodialysis
may not be elucidated in detail. Identifying the barriers and
enablers of home HD is only meaningful when probable
solutions to the issues projected from studies, are also pro-
vided. In addition, within the financial constraints of the
current health service provision, cost models and under-
standing optimal service delivery designs are fundamental
to effecting the desirable change.
The BASIC-HHD study has been designed to under-
stand the patient, the care-giver and the healthcare pro-
vider in a rapidly changing health care climate, where
emphasis on patient-centred choice and ‘care closer to
home’ remains at the core of NHS ethos. The strength
of this study lies in its methodology wherein a complexintervention of a life sustaining self-care technology is
systematically studied in a holistic sense incorporating
qualitative and quantitative research components studied
simultaneously with equal emphasis in centres with
varying prevalence and uptake of HHD. Incorporating
multiple research methods will help acquire a three di-
mensional view of the research findings, more likely to
yield lasting solutions to the research questions.
Health systems reforms, have in the last 20 years
evolved from provision of structured to managed care
as, structural changes, on their own may not be able to
deliver anticipated improvements in quality and per-
formance in health care [48]. This has not been studied
in a smaller context such as dialysis provision centres.
Organisational culture denotes much more than just the
way things are done and is a unique aspect of this study
arm. The study will analyse attitudes and practices in the
varying dialysis units. This may help distinguish frontline
service delivery (functional behaviour) from organiza-
tional (structural) influences.
The BASIC HHD is a pragmatic study, suitably equipped
with requisite expertise to carry out the work. We have
invested the effort and time to form a team of researchers
who are keen to study several facets of the research ques-
tion in parallel, from across UK. Prospective recruitment of
the pre-dialysis cohort will help understand the patient
journey better and we anticipate recruiting patients from
across the spectrum of illness severity. This will improve
the generalizability of our findings. Bias and random error
in handling data will be minimised by validation checks by
the researcher on data entry by research nurses. Periodic
visits to the participating units will ensure uninterrupted
and uniform data gathering, and an opportunity to trouble-
shoot problems as they arise. Conceptually, the BASIC-
HHD study is intended to be both confirmatory and
exploratory in design and provide a scaffold for ancillary
studies addressing specific psychosocial characteristics and
biomarkers in the different study cohorts. Planned studies
include an in-depth characterization of uraemic ‘neuro’-
toxins, namely the guanidino compounds and their impact
on cognitive outcomes and decision making processes in
ESRD. Exploratory work in search of a candidate biomarker
in biological samples (Blood spots and saliva) for cognitive
dysfunction in the context of ESRD is underway. It is also
likely that progression of the ‘uraemic state’ impacts on
physical factors such as, global DNA methylation, gene ex-
pression and metabolic pathways, which may influence
mental health and quality of life. Its associations with psy-
chological outcomes can now be combined to generate
valuable information, for patient care.
In conclusion, the BASIC-HHD is a unique study in dia-
lysis medicine, which will assemble pivotal information on
dialysis modality choice and uptake, investigating users,
caregivers and care delivery processes and study their
Jayanti et al. BMC Nephrology 2013, 14:197 Page 14 of 15
http://www.biomedcentral.com/1471-2369/14/197variation in a multi-layered analytical approach within a
single health care system. The study results would define
modality specific service and patient pathway redesign
with the potential of a paradigm shift in practice and pro-
viding future directions in dialysis care.
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